The University of Chicago Header Logo

Andrew Aronsohn

Concepts (150)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
14
2021
510
4.420
Why?
Hepatitis C
11
2022
208
3.900
Why?
Hepatitis C, Chronic
7
2020
126
2.810
Why?
Hepacivirus
5
2022
159
1.610
Why?
Gastroenterology
4
2021
134
1.410
Why?
Lactulose
1
2023
19
0.940
Why?
Hepatic Encephalopathy
1
2023
40
0.930
Why?
Liver Diseases
2
2016
238
0.840
Why?
Internship and Residency
4
2021
1004
0.810
Why?
Ribavirin
2
2013
57
0.810
Why?
Hypereosinophilic Syndrome
1
2021
5
0.800
Why?
Hepatitis, Autoimmune
1
2021
19
0.790
Why?
Off-Label Use
2
2014
16
0.600
Why?
Health Services Accessibility
3
2017
394
0.570
Why?
Hepatitis B, Chronic
1
2015
32
0.530
Why?
Interferon-alpha
2
2013
233
0.530
Why?
Informed Consent
2
2020
266
0.520
Why?
Viral Load
2
2021
148
0.500
Why?
Medicaid
1
2017
217
0.490
Why?
Polyethylene Glycols
2
2013
363
0.470
Why?
Interferons
1
2014
133
0.470
Why?
Drug Discovery
1
2013
103
0.420
Why?
Liver Transplantation
4
2023
1267
0.390
Why?
Biliary Tract Diseases
1
2011
34
0.390
Why?
Curriculum
4
2021
539
0.390
Why?
Resource Allocation
1
2011
65
0.390
Why?
Humans
28
2023
86601
0.380
Why?
Health Care Rationing
1
2011
83
0.380
Why?
Renal Insufficiency, Chronic
1
2015
350
0.380
Why?
Patient Participation
1
2012
216
0.380
Why?
Treatment Outcome
8
2021
7988
0.350
Why?
Liver Cirrhosis
3
2016
297
0.320
Why?
Tissue and Organ Procurement
1
2010
311
0.270
Why?
United States
7
2021
6665
0.260
Why?
Healthcare Disparities
2
2021
370
0.250
Why?
Vulnerable Populations
1
2022
76
0.210
Why?
United States Food and Drug Administration
2
2014
127
0.210
Why?
Proline
2
2013
57
0.210
Why?
Viremia
1
2021
54
0.200
Why?
Oligopeptides
2
2013
179
0.200
Why?
Donor Selection
1
2021
67
0.190
Why?
Azathioprine
1
2021
125
0.190
Why?
Prednisone
1
2021
258
0.190
Why?
Beneficence
1
2020
33
0.190
Why?
Risk Assessment
4
2021
2261
0.180
Why?
Recombinant Proteins
2
2013
1014
0.180
Why?
Drug Therapy, Combination
2
2014
894
0.180
Why?
Immunoglobulin G
1
2021
456
0.170
Why?
Glucocorticoids
1
2021
352
0.170
Why?
Anti-Bacterial Agents
1
2023
746
0.160
Why?
Ethics, Medical
1
2021
306
0.160
Why?
Tissue Donors
1
2021
463
0.160
Why?
Female
10
2021
44507
0.160
Why?
Legislation, Drug
1
2017
7
0.150
Why?
Gastrointestinal Microbiome
1
2023
455
0.150
Why?
Paracentesis
1
2016
8
0.140
Why?
Coinfection
2
2015
58
0.140
Why?
Flaviviridae Infections
1
2015
1
0.140
Why?
GB virus C
1
2015
1
0.140
Why?
Ascites
1
2016
55
0.140
Why?
Hepatitis, Viral, Human
1
2015
25
0.140
Why?
Internal Medicine
2
2016
347
0.140
Why?
Practice Patterns, Physicians'
1
2021
581
0.140
Why?
Immunosuppressive Agents
1
2021
977
0.130
Why?
Deficiency Diseases
1
2015
10
0.130
Why?
Career Choice
1
2016
139
0.130
Why?
Comorbidity
2
2015
943
0.130
Why?
Zinc
1
2015
91
0.130
Why?
Liver Failure
1
2015
78
0.120
Why?
Drug and Narcotic Control
1
2014
7
0.120
Why?
Time Factors
4
2021
5209
0.120
Why?
Viral Nonstructural Proteins
1
2014
37
0.120
Why?
Middle Aged
6
2021
25017
0.120
Why?
Protease Inhibitors
1
2014
72
0.120
Why?
Drug Design
1
2014
124
0.120
Why?
Liver Neoplasms
1
2020
735
0.120
Why?
Male
8
2021
40956
0.120
Why?
Drug Administration Schedule
1
2015
916
0.120
Why?
Acquired Immunodeficiency Syndrome
1
2014
78
0.120
Why?
Hepatitis B
1
2014
74
0.120
Why?
Drug Industry
1
2014
54
0.120
Why?
Disease Management
1
2015
327
0.110
Why?
Chronic Disease
1
2016
970
0.110
Why?
Algorithms
2
2020
1830
0.110
Why?
Truth Disclosure
1
2012
87
0.100
Why?
Molecular Targeted Therapy
1
2014
266
0.100
Why?
Dose-Response Relationship, Drug
1
2015
1961
0.100
Why?
Education, Medical, Graduate
1
2015
369
0.100
Why?
Physicians
1
2018
673
0.100
Why?
Clinical Competence
1
2016
751
0.100
Why?
Recurrence
1
2013
1139
0.090
Why?
Hospitalization
1
2016
848
0.090
Why?
Cohort Studies
2
2015
2767
0.090
Why?
Animals
2
2023
26581
0.090
Why?
Postoperative Period
1
2011
303
0.090
Why?
Decision Trees
1
2020
63
0.090
Why?
Severity of Illness Index
1
2015
1801
0.090
Why?
Mice
1
2023
11352
0.090
Why?
Precision Medicine
1
2013
395
0.090
Why?
Age Factors
1
2013
1849
0.080
Why?
Critical Illness
1
2011
294
0.080
Why?
Practice Guidelines as Topic
1
2015
1034
0.080
Why?
Critical Care
1
2011
370
0.080
Why?
Prognosis
1
2015
3674
0.080
Why?
Physician-Patient Relations
1
2012
610
0.070
Why?
Aged, 80 and over
2
2015
6501
0.070
Why?
Databases, Factual
2
2021
812
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2009
508
0.060
Why?
Mass Screening
2
2022
617
0.060
Why?
Aged
4
2016
18402
0.060
Why?
HIV Infections
1
2013
772
0.060
Why?
Clinical Trials as Topic
1
2009
1169
0.060
Why?
Fatty Acids
1
2023
130
0.060
Why?
Dysbiosis
1
2023
70
0.060
Why?
Feces
1
2023
319
0.050
Why?
Adult
3
2021
25640
0.050
Why?
Colorectal Neoplasms
1
2009
938
0.050
Why?
Risk Factors
3
2021
5416
0.050
Why?
RNA, Viral
1
2021
327
0.050
Why?
Clinical Decision-Making
1
2021
257
0.040
Why?
Chicago
1
2022
1379
0.040
Why?
Graft Survival
1
2021
884
0.040
Why?
Quality Improvement
1
2021
428
0.040
Why?
Cost Savings
1
2016
66
0.030
Why?
Hospital Costs
1
2016
104
0.030
Why?
Hospitals, University
1
2015
194
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
273
0.030
Why?
Quality Indicators, Health Care
1
2016
144
0.030
Why?
Early Diagnosis
1
2015
131
0.030
Why?
Statistics, Nonparametric
1
2015
307
0.030
Why?
Needs Assessment
1
2015
154
0.030
Why?
Hospital Mortality
1
2016
348
0.030
Why?
Linear Models
1
2015
421
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
879
0.030
Why?
Cost-Benefit Analysis
1
2016
451
0.030
Why?
Length of Stay
1
2016
700
0.030
Why?
Kaplan-Meier Estimate
1
2015
860
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2015
456
0.030
Why?
Multivariate Analysis
1
2015
999
0.030
Why?
Base Sequence
1
2015
2330
0.030
Why?
Molecular Sequence Data
1
2015
3030
0.020
Why?
Survival Rate
1
2015
1860
0.020
Why?
Phylogeny
1
2015
1137
0.020
Why?
Disease Progression
1
2015
1531
0.020
Why?
Tomography, X-Ray Computed
1
2020
2600
0.020
Why?
Family Health
1
2009
162
0.020
Why?
Health Education
1
2009
100
0.020
Why?
Follow-Up Studies
1
2015
3636
0.020
Why?
Retrospective Studies
1
2015
8475
0.010
Why?
Genetic Predisposition to Disease
1
2009
2270
0.010
Why?
Aronsohn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (150)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_